387 related articles for article (PubMed ID: 18356410)
21. Increased RhoA translocation in aorta of diabetic rats.
Tang J; Kusaka I; Massey AR; Rollins S; Zhang JH
Acta Pharmacol Sin; 2006 May; 27(5):543-8. PubMed ID: 16626508
[TBL] [Abstract][Full Text] [Related]
22. Phenylalanine activates the mitochondria-mediated apoptosis through the RhoA/Rho-associated kinase pathway in cortical neurons.
Zhang Y; Gu X; Yuan X
Eur J Neurosci; 2007 Mar; 25(5):1341-8. PubMed ID: 17425560
[TBL] [Abstract][Full Text] [Related]
23. Diabetes mellitus increases endothelin-1 gene transcription in rat kidney.
Hargrove GM; Dufresne J; Whiteside C; Muruve DA; Wong NC
Kidney Int; 2000 Oct; 58(4):1534-45. PubMed ID: 11012888
[TBL] [Abstract][Full Text] [Related]
24. A role for Rho-kinase in Ca-independent contractions induced by phorbol-12,13-dibutyrate.
Baek I; Jeon SB; Kim J; Seok YM; Song MJ; Chae SC; Jun JE; Park WH; Kim IK
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):256-61. PubMed ID: 18986333
[TBL] [Abstract][Full Text] [Related]
25. Hepatic expression profiling shows involvement of PKC epsilon, DGK eta, Tnfaip, and Rho kinase in type 2 diabetic nephropathy rats.
Gupta J; Gaikwad AB; Tikoo K
J Cell Biochem; 2010 Nov; 111(4):944-54. PubMed ID: 20665664
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats.
Wang J; Huang H; Liu P; Tang F; Qin J; Huang W; Chen F; Guo F; Liu W; Yang B
Eur J Pharmacol; 2006 Dec; 553(1-3):297-303. PubMed ID: 17074319
[TBL] [Abstract][Full Text] [Related]
27. High glucose-induced RhoA activation requires caveolae and PKCβ1-mediated ROS generation.
Zhang Y; Peng F; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F159-72. PubMed ID: 21975875
[TBL] [Abstract][Full Text] [Related]
28. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy.
Song HK; Lee MH; Kim BK; Park YG; Ko GJ; Kang YS; Han JY; Han SY; Han KH; Kim HK; Cha DR
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1485-94. PubMed ID: 18768589
[TBL] [Abstract][Full Text] [Related]
29. Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN.
Mahimainathan L; Das F; Venkatesan B; Choudhury GG
Diabetes; 2006 Jul; 55(7):2115-25. PubMed ID: 16804083
[TBL] [Abstract][Full Text] [Related]
30. Reduced IP receptors in STZ-induced diabetic rat kidneys and high-glucose-treated mesangial cells.
Nasrallah R; Hébert RL
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F673-81. PubMed ID: 15161601
[TBL] [Abstract][Full Text] [Related]
31. TGR5 suppresses high glucose-induced upregulation of fibronectin and transforming growth factor-β1 in rat glomerular mesangial cells by inhibiting RhoA/ROCK signaling.
Xiong F; Li X; Yang Z; Wang Y; Gong W; Huang J; Chen C; Liu P; Huang H
Endocrine; 2016 Dec; 54(3):657-670. PubMed ID: 27470217
[TBL] [Abstract][Full Text] [Related]
32. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice.
Dai C; Yang J; Bastacky S; Xia J; Li Y; Liu Y
J Am Soc Nephrol; 2004 Oct; 15(10):2637-47. PubMed ID: 15466268
[TBL] [Abstract][Full Text] [Related]
33. [Phenotypic and functional alterations of mesangial cells in patients with diabetic nephropathy].
Liu Z; Chen Z; Li Y
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1369-73. PubMed ID: 11930630
[TBL] [Abstract][Full Text] [Related]
34. Expression of RhoA mRNA and activated RhoA in urothelium and smooth muscle, and effects of a Rho-kinase inhibitor on contraction of the porcine urinary bladder.
Nakanishi K; Kamai T; Mizuno T; Arai K; Yamanishi T
Neurourol Urodyn; 2009; 28(6):521-8. PubMed ID: 19214992
[TBL] [Abstract][Full Text] [Related]
35. Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells.
Wu D; Peng F; Zhang B; Ingram AJ; Gao B; Krepinsky JC
Diabetologia; 2007 Sep; 50(9):2008-2018. PubMed ID: 17622510
[TBL] [Abstract][Full Text] [Related]
36. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
[TBL] [Abstract][Full Text] [Related]
37. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.
Guilluy C; Eddahibi S; Agard C; Guignabert C; Izikki M; Tu L; Savale L; Humbert M; Fadel E; Adnot S; Loirand G; Pacaud P
Am J Respir Crit Care Med; 2009 Jun; 179(12):1151-8. PubMed ID: 19299501
[TBL] [Abstract][Full Text] [Related]
38. Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications.
Chen S; Khan ZA; Cukiernik M; Chakrabarti S
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1089-97. PubMed ID: 12582013
[TBL] [Abstract][Full Text] [Related]
39. Erectile response to type 5 phosphodiesterase inhibitor could be preserved with the addition of simvastatin to conventional insulin treatment in rat model of diabetes.
Park K; Cho SY; Kim SW
Int J Androl; 2011 Oct; 34(5 Pt 2):e468-74. PubMed ID: 21790657
[TBL] [Abstract][Full Text] [Related]
40. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
